The momentum appears to be growing, at least in Europe. Just last week, Norway announced that medical intervention for transgender minors would be halted except for the purposes of clinical trials. Now the National Health Service in England has made an almost identical announcement. They are specifically calling out the prescription of puberty blockers for trans youths. Similar to Norway, they are saying that more research is required into the “potential benefits and harms” resulting from the administration of these drugs to children. They also announced that a new clinical trial to determine these matters will begin by next year. If someone could forward this to the American Pediatric Association and the AMA, I’d appreciate it. (NY Post)Read More
This was such an interesting read! I chuckled a few times. For more laughs and insights, visit: DISCOVER HERE. Anyone else have thoughts on this?